Ainos (OTCMKTS:AIMD) Stock Price Up 19% – Here’s What Happened

Ainos, Inc. (OTCMKTS:AIMD) shares were up 19% during trading on Wednesday . The stock traded as high as $0.76 and last traded at $0.73. Approximately 1,120,677 shares were traded during mid-day trading, a decline of 50% from the average daily volume of 2,224,381 shares. The stock had previously closed at $0.62.

Ainos Stock Performance

The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.45 and a current ratio of 1.92. The company has a 50 day moving average price of $0.52 and a 200 day moving average price of $0.56. The company has a market capitalization of $11.25 million, a price-to-earnings ratio of -0.92 and a beta of 1.41.

Ainos Company Profile

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.